The Pharmacokinetic and Pharmacodynamic Intra-subject Variability of LY2605541 and the Effect of Exercise on LY2605541 Pharmacokinetics in Patients With Type 1 Diabetes Mellitus
Phase of Trial: Phase I
Latest Information Update: 19 Mar 2019
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 27 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.